Hanmi Pharm presents study results of LAPSCOVERY at ADA
2 candidate substances of biologic applied with ‘LAPSCOVERY,’ Hanmi Pharm’s own platform technology, were revealed at the world’s largest diabetes association American Diabetes Association(ADA).
Hanmi Pharm(CEO Sae-Chang Kwon, Jong-Soo Woo) announced on the 14th the company participated in the 7...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.